Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jang Woo Ha

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|November 14, 2023
Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre StudyJang Woo Ha, Yong-Beom Park, Sang-Won Lee
Journal of Clinical Medicine|March 27, 2025
Circulating GDF15 May Estimate Vasculitis Activity and Predict Poor Outcomes During the Disease Course of ANCA-Associated VasculitisTaejun Yoon, Jang Woo Ha, Yong-Beom Park, et al.
Clinical and Experimental Rheumatology|October 22, 2024
Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitisTaejun Yoon, Jang Woo Ha, Yong-Beom Park, et al.
Frontiers in Molecular Biosciences|February 24, 2025
Serum glutathione peroxidase-3 concentration at diagnosis as a biomarker for assessing disease activity and damage of antineutrophil cytoplasmic antibody-associated vasculitis at diagnosisJihye Chung, Jang Woo Ha, Yong-Beom Park, et al.
Clinical Rheumatology|July 8, 2022
BVAS version 3 and BVAS/GPA: standing on the same line?Sung Soo Ahn, Jang Woo Ha, Yong-Beom Park, et al.
Frontiers in Medicine|January 28, 2026
Clinical utility of proteinase 3-antineutrophil cytoplasmic antibody at diagnosis in predicting subsequent relapse in patients with microscopic polyangiitisJang Woo Ha, Oh Chan Kwon, Yong-Beom Park, et al.
Modern Rheumatology|January 9, 2025
Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritisJang Woo Ha, Jason Jungsik Song, Yong-Beom Park, et al.
Rheumatology (Oxford, England)|July 28, 2021
Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?Sung Soo Ahn, Jang Woo Ha, Yong-Beom Park, et al.
Frontiers in Medicine|August 22, 2025
A new formula consisting of the five-factor score and earliest vasculitis damage index at diagnosis for predicting poor outcomes of antineutrophil cytoplasmic antibody-associated vasculitisJang Woo Ha, Oh Chan Kwon, Yong-Beom Park, et al.
Journal of Clinical Medicine|October 16, 2024
Clinical Significance of Overlap Syndrome of Histologically Confirmed Lupus Nephritis with Antineutrophil Cytoplasmic Antibody-Associated VasculitisJeong Yeop Whang, Jang Woo Ha, Yong-Beom Park, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|November 14, 2023
Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre StudyJang Woo Ha, Yong-Beom Park, Sang-Won Lee
Journal of Clinical Medicine|March 27, 2025
Circulating GDF15 May Estimate Vasculitis Activity and Predict Poor Outcomes During the Disease Course of ANCA-Associated VasculitisTaejun Yoon, Jang Woo Ha, Yong-Beom Park, et al.
Clinical and Experimental Rheumatology|October 22, 2024
Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitisTaejun Yoon, Jang Woo Ha, Yong-Beom Park, et al.
Frontiers in Molecular Biosciences|February 24, 2025
Serum glutathione peroxidase-3 concentration at diagnosis as a biomarker for assessing disease activity and damage of antineutrophil cytoplasmic antibody-associated vasculitis at diagnosisJihye Chung, Jang Woo Ha, Yong-Beom Park, et al.
Clinical Rheumatology|July 8, 2022
BVAS version 3 and BVAS/GPA: standing on the same line?Sung Soo Ahn, Jang Woo Ha, Yong-Beom Park, et al.
Frontiers in Medicine|January 28, 2026
Clinical utility of proteinase 3-antineutrophil cytoplasmic antibody at diagnosis in predicting subsequent relapse in patients with microscopic polyangiitisJang Woo Ha, Oh Chan Kwon, Yong-Beom Park, et al.
Modern Rheumatology|January 9, 2025
Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritisJang Woo Ha, Jason Jungsik Song, Yong-Beom Park, et al.
Rheumatology (Oxford, England)|July 28, 2021
Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?Sung Soo Ahn, Jang Woo Ha, Yong-Beom Park, et al.
Frontiers in Medicine|August 22, 2025
A new formula consisting of the five-factor score and earliest vasculitis damage index at diagnosis for predicting poor outcomes of antineutrophil cytoplasmic antibody-associated vasculitisJang Woo Ha, Oh Chan Kwon, Yong-Beom Park, et al.
Journal of Clinical Medicine|October 16, 2024
Clinical Significance of Overlap Syndrome of Histologically Confirmed Lupus Nephritis with Antineutrophil Cytoplasmic Antibody-Associated VasculitisJeong Yeop Whang, Jang Woo Ha, Yong-Beom Park, et al.
Pageof 6